Meds Apotek AB (publ) (OSTO:MEDS) PE Ratio: 33.60 (As of Jul. 22, 2026) — 47% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MEDS Meds Apotek AB (publ) OSTO:MEDS
11 GF Score
Price kr25.20
! 2 Warning Signs
View Full Analysis

What is Meds Apotek AB (publ) PE Ratio?

Meds Apotek AB (publ) OSTO:MEDS +18.31% 11 PE Ratio is 33.60 as of Jul. 22, 2026, which is 47% below its 10-year median of 62.84. GuruFocus rates OSTO:MEDS with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-22), Meds Apotek AB (publ)'s share price is kr25.20. Meds Apotek AB (publ)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.75. Therefore, Meds Apotek AB (publ)'s PE Ratio for today is 33.60.

Good Sign:

Meds Apotek AB (publ) stock PE Ratio (=46.59) is close to 1-year low of 46.59.

During the past 4 years, Meds Apotek AB (publ)'s highest PE Ratio was 224.00. The lowest was 46.59. And the median was 62.84.

Meds Apotek AB (publ)'s EPS (Diluted) for the three months ended in Jun. 2026 was kr0.31. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.75.

As of today (2026-07-22), Meds Apotek AB (publ)'s share price is kr25.20. Meds Apotek AB (publ)'s EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.75. Therefore, Meds Apotek AB (publ)'s PE Ratio without NRI ratio for today is 33.60.

During the past 4 years, Meds Apotek AB (publ)'s highest PE Ratio without NRI was 224.00. The lowest was 46.59. And the median was 62.84.

Meds Apotek AB (publ)'s EPS without NRI for the three months ended in Jun. 2026 was kr0.31. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.75.

Meds Apotek AB (publ)'s EPS (Basic) for the three months ended in Jun. 2026 was kr0.31. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.79.

Back to Basics: PE Ratio


Meds Apotek AB (publ)  (OSTO:MEDS) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Meds Apotek AB (publ) PE Ratio Related Terms


Meds Apotek AB (publ) PE Ratio Historical Data

* Premium members only.

The historical data trend for Meds Apotek AB (publ)'s PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meds Apotek AB (publ) PE Ratio Chart

Meds Apotek AB (publ) Annual Data
Trend Dec21 Dec23 Dec24 Dec25
PE Ratio
N/A N/A N/A 115.81

Meds Apotek AB (publ) Quarterly Data
Dec21 Jun22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only At Loss At Loss 115.81 67.27 At Loss

OSTO:MEDS vs AMZN, BABA, PDD: PE Ratio Comparison

For the Internet Retail subindustry, Meds Apotek AB (publ)'s PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meds Apotek AB (publ) PE Ratio vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s PE Ratio distribution charts can be found below:

* The bar in red indicates where Meds Apotek AB (publ)'s PE Ratio falls into.


OSTO:MEDS
11GF Score
Meds Apotek AB (publ) OSTO:MEDS
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meds Apotek AB (publ) PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Meds Apotek AB (publ)'s PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=25.20/0.750
=33.6

Meds Apotek AB (publ)'s Share Price of today is kr25.20.
Meds Apotek AB (publ)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.75.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 33.60 mean?
Meds Apotek AB (publ) (OSTO:MEDS) has a PE Ratio of 33.60 as of Jul. 22, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Meds Apotek AB (publ) and its competitors. This is 47% below median its historical median of 62.84. Over the past decade, Meds Apotek AB (publ)'s PE Ratio has ranged from 46.59 to 224.00.
Is Meds Apotek AB (publ)'s PE Ratio too high?
Meds Apotek AB (publ)'s current PE Ratio of 33.60 is 47% below median its 10-year median of 62.84. Over the past 10 years, this metric has ranged from a low of 46.59 to a high of 224.00. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s PE Ratio compare to AMZN and BABA?
Meds Apotek AB (publ)'s PE Ratio of 33.60 can be compared against companies in the Retail - Cyclical industry. Historically, Meds Apotek AB (publ)'s own PE Ratio has ranged from 46.59 to 224.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Retail - Cyclical company?
A good PE Ratio depends on the Retail - Cyclical industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Meds Apotek AB (publ) and its competitors. Meds Apotek AB (publ)'s current PE Ratio is 33.60, which is 47% below median its own 10-year median of 62.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (OSTO:MEDS) has a current PE Ratio of 33.60. The current PE Ratio is 33.60, which is 47% below median its 10-year median of 62.84. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Meds Apotek AB (publ) (OSTO:MEDS), the current PE Ratio is 33.60 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Meds Apotek AB (publ) Business Description

Address Elektravagen 26, Port 136, Hagersten, Stockholm, SWE, 12630
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score

Get the complete analysis for OSTO:MEDS

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr25.20
Price